Dr. Gino J. Sedillo, MD

Dr. Sedillo practices at Cardiovascular Solutions Institute in Bradenton, Florida.

Dr. Sedillo's NPI, 1982680179, was assigned on December 20, 2005. Dr. Sedillo graduated from Tecnologico de Monterrey Escuela de Medicina in 1990. Dr. Sedillo holds Florida license ME0076343.

Dr. Sedillo's primary practice is Cardiovascular Solutions Institute, at 2210 61st St W, Bradenton, FL 34209-5527. The practice phone is (941) 747-8789.

Dr. Sedillo's primary practice is Cardiovascular Solutions Institute in Bradenton, Florida. Dr. Sedillo is also affiliated with Lakewood Ranch Medical Center. The medical group on file is CardioVascular Solutions Institute. Dmand AI also links Dr. Sedillo to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sedillo practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sedillo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Sedillo is board certified in internal medicine by the National Board of Physicians and Surgeons. Dmand AI has Dr. Sedillo's licenses on file in 3 states: Florida, Texas and Pennsylvania.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization and pacemaker or defibrillator implantation among the conditions Dr. Sedillo treats.

CMS data shows 5,698 Medicare services from Dr. Sedillo across 47 procedure codes in 2024, for 1,115 Medicare patients. Medicare paid $1,007,118 for them.

CMS counts 1,115 Medicare patients who saw Dr. Sedillo in 2024. The largest group is 75 to 84, with 470 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sedillo's median patient age at 77, with 42% women.

In 2024, Dr. Sedillo wrote 2,007 Medicare Part D claims for 484 patients. 87% of them were for generic drugs. CMS names the drug for 1,788 of them, across 33 drugs with 11 or more claims each, at $219,678 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Sedillo for performance year 2024, reported individually. Dr. Sedillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 127 procedures of coronary angioplasty and stenting by Dr. Sedillo, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Sedillo. The most frequent topics are Amputation, Surgical, Angioplasty, Balloon and Arterial Occlusive Diseases. Dr. Sedillo has published most often in J Endovasc Ther. Dr. Sedillo's most frequent co-authors are Tony S. Das, MD, Bruce Harvey Gray, DO and Kenneth R. Kollmeyer, MD.

Dmand AI links Dr. Sedillo to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 230 general payments to Dr. Sedillo from 23 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 51% of the total. W. L. Gore & Associates, Inc. paid the most, $8,093.

Dmand AI lists 2 awards for Dr. Sedillo, most recently ACC Fellow in 2013.

Dr. Sedillo graduated from Tecnologico de Monterrey Escuela de Medicina in 1990. Dr. Sedillo is a member of ACC.

Dr. Sedillo is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.